The mitochondrial (mt) FoF1-ATP synthase of the digenetic parasite, Trypanosoma brucei, generates ATP during the insect procyclic form (PF), but becomes a perpetual consumer of ATP in the mammalian bloodstream form (BF), which lacks a canonical respiratory chain. This unconventional dependence on FoF1-ATPase is required to maintain the essential mt membrane potential (Δψm). Normally, ATP hydrolysis by this rotary molecular motor is restricted to when eukaryotic cells experience sporadic hypoxic conditions, during which this compulsory function quickly depletes the cellular ATP pool. To protect against this cellular treason, the highly conserved inhibitory factor 1 (IF1) binds the enzyme in a manner that solely inhibits the hydrolytic activity. Intriguingly, we were able to identify the IF1 homolog in T. brucei (TbIF1), but determined that its expression in the mitochondrion is tightly regulated throughout the life cycle as it is only detected in PF cells. TbIF1 appears to primarily function as an emergency brake in PF cells, where it prevented the restoration of the Δψm by FoF1-ATPase when respiration was chemically inhibited. In vitro, TbIF1 overexpression specifically inhibits the hydrolytic activity but not the synthetic capability of the FoF1-ATP synthase in PF mitochondria. Furthermore, low μM amounts of recombinant TbIF1 achieve the same inhibition of total mt ATPase activity as the FoF1-ATPase specific inhibitors, azide and oligomycin. Therefore, even minimal ectopic expression of TbIF1 in BF cells proved lethal as the indispensable Δψm collapsed due to inhibited FoF1-ATPase. In summary, we provide evidence that T. brucei harbors a natural and potent unidirectional inhibitor of the vital FoF1-ATPase activity that can be exploited for future structure-based drug design.

Biology Centre Czech Academy of Sciences Institute of Parasitology Ceske Budejovice Czech Republic

Faculty of Science University of South Bohemia Ceske Budejovice Czech Republic

Zobrazit více v PubMed

Matthews KR (2015) 25 years of African trypanosome research: From description to molecular dissection and new drug discovery. Mol Biochem Parasitol 200: 30–40. 10.1016/j.molbiopara.2015.01.006 PubMed DOI PMC

Matthews KR (2005) The developmental cell biology of Trypanosoma brucei. J Cell Sci 118: 283–290. 10.1242/jcs.01649 PubMed DOI PMC

Tielens AG, Van Hellemond JJ (1998) Differences in energy metabolism between trypanosomatidae. Parasitol Today 14: 265–272. PubMed

van Hellemond JJ, Opperdoes FR, Tielens AG (2005) The extraordinary mitochondrion and unusual citric acid cycle in Trypanosoma brucei. Biochem Soc Trans 33: 967–971. 10.1042/BST20050967 PubMed DOI

Bringaud F, Riviere L, Coustou V (2006) Energy metabolism of trypanosomatids: adaptation to available carbon sources. Mol Biochem Parasitol 149: 1–9. 10.1016/j.molbiopara.2006.03.017 PubMed DOI

Zikova A, Schnaufer A, Dalley RA, Panigrahi AK, Stuart KD (2009) The F(0)F(1)-ATP synthase complex contains novel subunits and is essential for procyclic Trypanosoma brucei. PLoS Pathog 5: e1000436 10.1371/journal.ppat.1000436 PubMed DOI PMC

Michels PA, Bringaud F, Herman M, Hannaert V (2006) Metabolic functions of glycosomes in trypanosomatids. Biochim Biophys Acta 1763: 1463–1477. 10.1016/j.bbamcr.2006.08.019 PubMed DOI

Stephens JL, Lee SH, Paul KS, Englund PT (2007) Mitochondrial fatty acid synthesis in Trypanosoma brucei. J Biol Chem 282: 4427–4436. 10.1074/jbc.M609037200 PubMed DOI

Schnaufer A, Panigrahi AK, Panicucci B, Igo RP Jr., Wirtz E, et al. (2001) An RNA ligase essential for RNA editing and survival of the bloodstream form of Trypanosoma brucei. Science 291: 2159–2162. PubMed

Huang G, Vercesi AE, Docampo R (2013) Essential regulation of cell bioenergetics in Trypanosoma brucei by the mitochondrial calcium uniporter. Nat Commun 4: 2865 10.1038/ncomms3865 PubMed DOI PMC

Mazet M, Morand P, Biran M, Bouyssou G, Courtois P, et al. (2013) Revisiting the central metabolism of the bloodstream forms of Trypanosoma brucei: production of acetate in the mitochondrion is essential for parasite viability. PLoS Negl Trop Dis 7: e2587 10.1371/journal.pntd.0002587 PubMed DOI PMC

Neupert W (1997) Protein import into mitochondria. Annu Rev Biochem 66: 863–917. 10.1146/annurev.biochem.66.1.863 PubMed DOI

Nolan DP, Voorheis HP (1992) The mitochondrion in bloodstream forms of Trypanosoma brucei is energized by the electrogenic pumping of protons catalysed by the F1F0-ATPase. Eur J Biochem 209: 207–216. PubMed

Lai DH, Hashimi H, Lun ZR, Ayala FJ, Lukes J (2008) Adaptations of Trypanosoma brucei to gradual loss of kinetoplast DNA: Trypanosoma equiperdum and Trypanosoma evansi are petite mutants of T. brucei. Proc Natl Acad Sci U S A 105: 1999–2004. 10.1073/pnas.0711799105 PubMed DOI PMC

Dean S, Gould MK, Dewar CE, Schnaufer AC (2013) Single point mutations in ATP synthase compensate for mitochondrial genome loss in trypanosomes. Proc Natl Acad Sci U S A 110: 14741–14746. 10.1073/pnas.1305404110 PubMed DOI PMC

Subrtova K, Panicucci B, Zikova A (2015) ATPaseTb2, a Unique Membrane-bound FoF1-ATPase Component, Is Essential in Bloodstream and Dyskinetoplastic Trypanosomes. PLoS Pathog 11: e1004660 10.1371/journal.ppat.1004660 PubMed DOI PMC

St-Pierre J, Brand MD, Boutilier RG (2000) Mitochondria as ATP consumers: cellular treason in anoxia. Proc Natl Acad Sci U S A 97: 8670–8674. 10.1073/pnas.140093597 PubMed DOI PMC

Grover GJ, Atwal KS, Sleph PG, Wang FL, Monshizadegan H, et al. (2004) Excessive ATP hydrolysis in ischemic myocardium by mitochondrial F1F0-ATPase: effect of selective pharmacological inhibition of mitochondrial ATPase hydrolase activity. Am J Physiol Heart Circ Physiol 287: H1747–1755. 10.1152/ajpheart.01019.2003 PubMed DOI

Pullman ME, Monroy GC (1963) A Naturally Occurring Inhibitor of Mitochondrial Adenosine Triphosphatase. J Biol Chem 238: 3762–3769. PubMed

Norling B, Tourikas C, Hamasur B, Glaser E (1990) Evidence for an endogenous ATPase inhibitor protein in plant mitochondria. Purification and characterization. Eur J Biochem 188: 247–252. PubMed

Ichikawa N, Ando C, Fumino M (2006) Caenorhabditis elegans MAI-1 protein, which is similar to mitochondrial ATPase inhibitor (IF1), can inhibit yeast F0F1-ATPase but cannot be transported to yeast mitochondria. J Bioenerg Biomembr 38: 93–99. 10.1007/s10863-006-9009-2 PubMed DOI

Ichikawa N, Yoshida Y, Hashimoto T, Ogasawara N, Yoshikawa H, et al. (1990) Activation of ATP hydrolysis by an uncoupler in mutant mitochondria lacking an intrinsic ATPase inhibitor in yeast. J Biol Chem 265: 6274–6278. PubMed

Bason JV, Montgomery MG, Leslie AGW, Walker JE (2014) Pathway of binding of the intrinsically disordered mitochondrial inhibitor protein to F-1-ATPase. Proceedings of the National Academy of Sciences of the United States of America 111: 11305–11310. 10.1073/pnas.1411560111 PubMed DOI PMC

Gledhill JR, Montgomery MG, Leslie AG, Walker JE (2007) How the regulatory protein, IF(1), inhibits F(1)-ATPase from bovine mitochondria. Proc Natl Acad Sci U S A 104: 15671–15676. 10.1073/pnas.0707326104 PubMed DOI PMC

Runswick MJ, Bason JV, Montgomery MG, Robinson GC, Fearnley IM, et al. (2013) The affinity purification and characterization of ATP synthase complexes from mitochondria. Open Biol 3: 120160 10.1098/rsob.120160 PubMed DOI PMC

Campanella M, Parker N, Tan CH, Hall AM, Duchen MR (2009) IF(1): setting the pace of the F(1)F(o)-ATP synthase. Trends Biochem Sci 34: 343–350. 10.1016/j.tibs.2009.03.006 PubMed DOI

Campanella M, Casswell E, Chong S, Farah Z, Wieckowski MR, et al. (2008) Regulation of mitochondrial structure and function by the F1Fo-ATPase inhibitor protein, IF1. Cell Metab 8: 13–25. 10.1016/j.cmet.2008.06.001 PubMed DOI

Garcia-Bermudez J, Cuezva JM (2016) The ATPase Inhibitory Factor 1 (IF1): A master regulator of energy metabolism and of cell survival. Biochimica Et Biophysica Acta-Bioenergetics 1857: 1167–1182. PubMed

Faccenda D, Nakamura J, Gorini G, Dhoot GK, Piacentini M, et al. (2017) Control of Mitochondrial Remodeling by the ATPase Inhibitory Factor 1 Unveils a Pro-survival Relay via OPA1. Cell Rep 18: 1869–1883. 10.1016/j.celrep.2017.01.070 PubMed DOI

Wang Z, Morris JC, Drew ME, Englund PT (2000) Inhibition of Trypanosoma brucei gene expression by RNA interference using an integratable vector with opposing T7 promoters. J Biol Chem 275: 40174–40179. 10.1074/jbc.M008405200 PubMed DOI

Flaspohler JA, Jensen BC, Saveria T, Kifer CT, Parsons M (2010) A novel protein kinase localized to lipid droplets is required for droplet biogenesis in trypanosomes. Eukaryot Cell 9: 1702–1710. 10.1128/EC.00106-10 PubMed DOI PMC

Wirtz E, Leal S, Ochatt C, Cross GA (1999) A tightly regulated inducible expression system for conditional gene knock-outs and dominant-negative genetics in Trypanosoma brucei. Mol Biochem Parasitol 99: 89–101. PubMed

Stuart KD (1971) Evidence for the retention of kinetoplast DNA in an acriflavine-induced dyskinetoplastic strain of Trypanosoma brucei which replicates the altered central element of the kinetoplast. J Cell Biol 49: 189–195. PubMed PMC

Schnaufer A, Clark-Walker GD, Steinberg AG, Stuart K (2005) The F1-ATP synthase complex in bloodstream stage trypanosomes has an unusual and essential function. EMBO J 24: 4029–4040. 10.1038/sj.emboj.7600862 PubMed DOI PMC

Law RH, Manon S, Devenish RJ, Nagley P (1995) ATP synthase from Saccharomyces cerevisiae. Methods Enzymol 260: 133–163. PubMed

Pullman ME, Penefsky HS, Datta A, Racker E (1960) Partial resolution of the enzymes catalyzing oxidative phosphorylation. I. Purification and properties of soluble dinitrophenol-stimulated adenosine triphosphatase. J Biol Chem 235: 3322–3329. PubMed

Allemann N, Schneider A (2000) ATP production in isolated mitochondria of procyclic Trypanosoma brucei. Mol Biochem Parasitol 111: 87–94. PubMed

Gnipova A, Subrtova K, Panicucci B, Horvath A, Lukes J, et al. (2015) The ADP/ATP carrier and its relationship to OXPHOS in an ancestral protist, Trypanosoma brucei. Eukaryot Cell. PubMed PMC

Silvester JA, Dickson VK, Runswick MJ, Leslie AG, Walker JE (2006) The expression, purification, crystallization and preliminary X-ray analysis of a subcomplex of the peripheral stalk of ATP synthase from bovine mitochondria. Acta Crystallogr Sect F Struct Biol Cryst Commun 62: 530–533. 10.1107/S1744309106015338 PubMed DOI PMC

Miroux B, Walker JE (1996) Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels. J Mol Biol 260: 289–298. 10.1006/jmbi.1996.0399 PubMed DOI

Claros MG, Vincens P (1996) Computational method to predict mitochondrially imported proteins and their targeting sequences. Eur J Biochem 241: 779–786. PubMed

van Raaij MJ, Orriss GL, Montgomery MG, Runswick MJ, Fearnley IM, et al. (1996) The ATPase inhibitor protein from bovine heart mitochondria: the minimal inhibitory sequence. Biochemistry 35: 15618–15625. 10.1021/bi960628f PubMed DOI

Cabezon E, Runswick MJ, Leslie AG, Walker JE (2001) The structure of bovine IF(1), the regulatory subunit of mitochondrial F-ATPase. EMBO J 20: 6990–6996. 10.1093/emboj/20.24.6990 PubMed DOI PMC

Ichikawa N, Ushida S, Kawabata M, Masazumi Y (1999) Nucleotide sequence of cDNA coding the mitochondrial precursor protein of the ATPase inhibitor from humans. Biosci Biotechnol Biochem 63: 2225–2227. 10.1271/bbb.63.2225 PubMed DOI

Cabezon E, Arechaga I, Jonathan P, Butler G, Walker JE (2000) Dimerization of bovine F1-ATPase by binding the inhibitor protein, IF1. J Biol Chem 275: 28353–28355. 10.1074/jbc.C000427200 PubMed DOI

Luscher A, Lamprea-Burgunder E, Graf FE, de Koning HP, Maser P (2014) Trypanosoma brucei adenine-phosphoribosyltransferases mediate adenine salvage and aminopurinol susceptibility but not adenine toxicity. Int J Parasitol Drugs Drug Resist 4: 55–63. 10.1016/j.ijpddr.2013.12.001 PubMed DOI PMC

Chen Y, Hung CH, Burderer T, Lee GS (2003) Development of RNA interference revertants in Trypanosoma brucei cell lines generated with a double stranded RNA expression construct driven by two opposing promoters. Mol Biochem Parasitol 126: 275–279. PubMed

Figueira TR, Melo DR, Vercesi AE, Castilho RF (2012) Safranine as a fluorescent probe for the evaluation of mitochondrial membrane potential in isolated organelles and permeabilized cells. Methods Mol Biol 810: 103–117. 10.1007/978-1-61779-382-0_7 PubMed DOI

Inoue M, Nakamura Y, Yasuda K, Yasaka N, Hara T, et al. (2005) The 14-3-3 proteins of Trypanosoma brucei function in motility, cytokinesis, and cell cycle. J Biol Chem 280: 14085–14096. 10.1074/jbc.M412336200 PubMed DOI

Tsunoda SP, Rodgers AJ, Aggeler R, Wilce MC, Yoshida M, et al. (2001) Large conformational changes of the epsilon subunit in the bacterial F1F0 ATP synthase provide a ratchet action to regulate this rotary motor enzyme. Proc Natl Acad Sci U S A 98: 6560–6564. 10.1073/pnas.111128098 PubMed DOI PMC

Zarco-Zavala M, Morales-Rios E, Mendoza-Hernandez G, Ramirez-Silva L, Perez-Hernandez G, et al. (2014) The zeta subunit of the F1FO-ATP synthase of alpha-proteobacteria controls rotation of the nanomotor with a different structure. FASEB J 28: 2146–2157. 10.1096/fj.13-241430 PubMed DOI

Ketcham SR, Davenport JW, Warncke K, McCarty RE (1984) Role of the gamma subunit of chloroplast coupling factor 1 in the light-dependent activation of photophosphorylation and ATPase activity by dithiothreitol. J Biol Chem 259: 7286–7293. PubMed

Cintron NM, Pedersen PL (1979) Purification of an ATPase inhibitor peptide fraction from rat liver mitochondria. Methods Enzymol 55: 408–414. PubMed

Lu YM, Miyazawa K, Yamaguchi K, Nowaki K, Iwatsuki H, et al. (2001) Deletion of mitochondrial ATPase inhibitor in the yeast Saccharomyces cerevisiae decreased cellular and mitochondrial ATP levels under non-nutritional conditions and induced a respiration-deficient cell-type. J Biochem 130: 873–878. PubMed

Fujikawa M, Imamura H, Nakamura J, Yoshida M (2012) Assessing actual contribution of IF1, inhibitor of mitochondrial FoF1, to ATP homeostasis, cell growth, mitochondrial morphology, and cell viability. J Biol Chem 287: 18781–18787. 10.1074/jbc.M112.345793 PubMed DOI PMC

Nakamura J, Fujikawa M, Yoshida M (2013) IF1, a natural inhibitor of mitochondrial ATP synthase, is not essential for the normal growth and breeding of mice. Biosci Rep 33. PubMed PMC

Hill GC, Degn H (1977) Steady-State Oxygen Kinetics of Cyanide-Insensitive Oxidase in Trypanosomes. Federation Proceedings 36: 905–905.

Hill GC, Degn H (1977) Steady-State Oxygen Kinetics of Terminal Oxidases in Trypanosoma-Mega. Journal of Protozoology 24: 563–565. PubMed

Kolev NG, Ramey-Butler K, Cross GAM, Ullu E, Tschudi C (2012) Developmental Progression to Infectivity in Trypanosoma brucei Triggered by an RNA-Binding Protein. Science 338: 1352–1353. 10.1126/science.1229641 PubMed DOI PMC

Fadda A, Ryten M, Droll D, Rojas F, Farber V, et al. (2014) Transcriptome-wide analysis of trypanosome mRNA decay reveals complex degradation kinetics and suggests a role for co-transcriptional degradation in determining mRNA levels. Mol Microbiol 94: 307–326. 10.1111/mmi.12764 PubMed DOI PMC

Kabani S, Fenn K, Ross A, Ivens A, Smith TK, et al. (2009) Genome-wide expression profiling of in vivo-derived bloodstream parasite stages and dynamic analysis of mRNA alterations during synchronous differentiation in Trypanosoma brucei. BMC Genomics 10: 427 10.1186/1471-2164-10-427 PubMed DOI PMC

Nilsson D, Gunasekera K, Mani J, Osteras M, Farinelli L, et al. (2010) Spliced leader trapping reveals widespread alternative splicing patterns in the highly dynamic transcriptome of Trypanosoma brucei. PLoS Pathog 6: e1001037 10.1371/journal.ppat.1001037 PubMed DOI PMC

Siegel TN, Hekstra DR, Wang X, Dewell S, Cross GA (2010) Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. Nucleic Acids Res 38: 4946–4957. 10.1093/nar/gkq237 PubMed DOI PMC

Jensen BC, Sivam D, Kifer CT, Myler PJ, Parsons M (2009) Widespread variation in transcript abundance within and across developmental stages of Trypanosoma brucei. BMC Genomics 10: 482 10.1186/1471-2164-10-482 PubMed DOI PMC

Urbaniak MD, Guther ML, Ferguson MA (2012) Comparative SILAC proteomic analysis of Trypanosoma brucei bloodstream and procyclic lifecycle stages. PLoS One 7: e36619 10.1371/journal.pone.0036619 PubMed DOI PMC

Butter F, Bucerius F, Michel M, Cicova Z, Mann M, et al. (2013) Comparative proteomics of two life cycle stages of stable isotope-labeled Trypanosoma brucei reveals novel components of the parasite's host adaptation machinery. Mol Cell Proteomics 12: 172–179. 10.1074/mcp.M112.019224 PubMed DOI PMC

Fidalgo LM, Gille L (2011) Mitochondria and trypanosomatids: targets and drugs. Pharm Res 28: 2758–2770. 10.1007/s11095-011-0586-3 PubMed DOI

Lanteri CA, Tidwell RR, Meshnick SR (2008) The mitochondrion is a site of trypanocidal action of the aromatic diamidine DB75 in bloodstream forms of Trypanosoma brucei. Antimicrob Agents Chemother 52: 875–882. 10.1128/AAC.00642-07 PubMed DOI PMC

Alkhaldi AA, Martinek J, Panicucci B, Dardonville C, Zikova A, et al. (2016) Trypanocidal action of bisphosphonium salts through a mitochondrial target in bloodstream form Trypanosoma brucei. Int J Parasitol Drugs Drug Resist 6: 23–34. 10.1016/j.ijpddr.2015.12.002 PubMed DOI PMC

Caffrey CR, Steverding D (2008) Recent initiatives and strategies to developing new drugs for tropical parasitic diseases. Expert Opin Drug Discov 3: 173–186. 10.1517/17460441.3.2.173 PubMed DOI

Dunny E, Doherty W, Evans P, Malthouse JP, Nolan D, et al. (2013) Vinyl sulfone-based peptidomimetics as anti-trypanosomal agents: design, synthesis, biological and computational evaluation. J Med Chem 56: 6638–6650. 10.1021/jm400294w PubMed DOI

Lampa AK, Bergman SM, Gustafsson SS, Alogheli H, Akerblom EB, et al. (2014) Novel Peptidomimetic Hepatitis C Virus NS3/4A Protease Inhibitors Spanning the P2-P1' Region. ACS Med Chem Lett 5: 249–254. 10.1021/ml400217r PubMed DOI PMC

Qiu X, Liu ZP (2011) Recent developments of peptidomimetic HIV-1 protease inhibitors. Curr Med Chem 18: 4513–4537. PubMed

Mitochondrion of the Trypanosoma brucei long slender bloodstream form is capable of ATP production by substrate-level phosphorylation

Redesigned and reversed: architectural and functional oddities of the trypanosomal ATP synthase

Bioenergetic consequences of FoF1-ATP synthase/ATPase deficiency in two life cycle stages of Trypanosoma brucei

Cell-based and multi-omics profiling reveals dynamic metabolic repurposing of mitochondria to drive developmental progression of Trypanosoma brucei

ATP synthase from Trypanosoma brucei has an elaborated canonical F1-domain and conventional catalytic sites